CSOP MicroStrategy Daily (-2x) Inverse Product (07399.HK) Rose 5.12%, with the Latest Price at HKD 26.280
Newtimespace News: As of 11:34 on May 19, the CSOP MicroStrategy Daily (-2x) Inverse Product (07399.HK) rose 5.12%, with the latest price at HKD 26.280, a high of HKD 26.440, a low of HKD 26.100, an average price of HKD 26.211, assets under management of approximately HKD 33 million, a latest net asset value of HKD 26.101, and a discount of 4.22%.
The CSOP MicroStrategy Daily (-2x) Inverse Product (07399.HK) is a leveraged inverse ETF that seeks to provide twice the inverse daily return of MicroStrategy common stock. MicroStrategy is a software company with a significant focus on Bitcoin holdings. The product uses derivatives such as swap contracts and futures to achieve leveraged exposure. Due to the compounding effect, its long-term returns may deviate from twice the inverse cumulative return of the underlying stock.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- iShares CSI 300 A-Share Index ETF (02846.HK) Rises 1.19% in Afternoon Trade, AUM at HKD 7.024 Billion
- XTX TECH HKEX Listing Application Lapses Upon Six-Month Expiry; Ranked 6th Globally Among Fabless Code-Type Flash Memory Chip Vendors
- Global X China Semiconductor ETF (03191.HK) Rises 6.91% in Afternoon Trade, Latest Price at HKD 116.000
- Premia CSI Caixin China New Economy ETF(03173.HK) Rises 1.21% Intraday with Average Traded Price of HK$10.840
- SIMCERE ZAIMING HKEX Listing Application Lapses Upon Six-Month Expiry; Recorded Most Out-Licensing Transactions Among Chinese Biopharma Firms in 2025